 The study aims to determine the feasibility of sampling and evaluability of biomarkers in CRPC tissue samples and circulating tumour cells CTCs. Exploratory biomarker analysis may include, but will not be limited to, understanding the potential proof of mechanism POM, proof of principle POP or predictive biomarkers of response to potential therapeutic agents for CRPC patients, or factors that may influence the development of CRPC. 